Find results that contain all of your keywords. Content filter is on. Search will return best illustrations, stock vectors and clipart.
Make it so!
You have chosen to exclude "" from your results.

Choose orientation:
Related commercial searches:

sirukumab

monoclonal

antibody

drug

targets

il

generic

 name stylized representation atlizumab humanized also known as tocilizumab interleukin receptor 6r used sarilumab mab therapy 3d illustration
of 44 ← →
Order by: relevancy of keywords | publishing date | most downloaded

Monoclonal Cartoons, Illustrations & Vector Stock Images

- 1186 images
Sirukumab monoclonal antibody drug. Targets IL-6. Generic name and stylized antibody representation.
Atlizumab humanized monoclonal antibody drug. Also known as tocilizumab. Targets the interleukin-6 receptor (IL-6R) and is used in
Sarilumab humanized monoclonal antibody drug. Also known as atlizumab. Targets the interleukin-6 receptor (IL-6R) and is used in
Monoclonal antibody (mAb) therapy - 3d illustration closeup view
Durvalumab monoclonal antibody drug. Targets Programmed cell Death-Ligand 1 (PD-L1) and is used in the treatment of cancer (immune
Monoclonal antibody (mAb) therapy - 3d illustration isometric view
Monoclonal antibodies (Adalimumab) - section view 3d illustration
Monoclonal antibodies (Adalimumab) - closeup view 3d illustration
Monoclonal antibodies (Adalimumab) - isometric view 3d illustration
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab,
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab,
CD38 (ectodomain fragment) enzyme. Target of the monoclonal antibody drug daratumumab, used for the treatment of multiple myeloma
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab,
Efalizumab monoclonal antibody drug. Targets CD11a but was withdrawn from the market due to safety issues. Generic name and
Monoclonal antibody treatment (Adalimumab) - closeup view 3d illustration
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug. Targets Programmed cell Death 1 (PD-1) and is used in the treatment of cancer (immune
Raxibacumab monoclonal antibody drug. Targets the Bacillus anthracis Protective Antigen and is intended for the prophylaxis and
Canakinumab monoclonal antibody drug molecule. Targets interleukin-1 beta and is used in the treatment of a number of auto-
Golimumab monoclonal antibody drug. Targets TNF-alpha. Indications for use include rheumatoid arthritis, psoriatic arthritis,
Fremanezumab monoclonal antibody drug. Targets calcitonin gene-related peptides (CGRP) A and B. Generic name and stylized antibody
Next Page
←↑↓→
See more images